An unusual clonal chromosome abnormality der(17)t(11;17)(q24;p13)inv(11)(q13;q23) in a patient with chronic lymphocytic leukemia
Article Sidebar
Main Article Content
Article Details
Copyright (c) 2021 Monti V, et al.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Archives of Case Reports is committed in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. In order to use the Open Access paradigm to the maximum extent in true terms as free of charge online access along with usage right, we grant usage rights through the use of specific Creative Commons license.
License: Copyright © 2017 - 2025 | 
Open Access by Archives of Case Reports is licensed under a Creative Commons Attribution 4.0 International License. Based on a work at Heighten Science Publications Inc.
With this license, the authors are allowed that after publishing with the journal, they can share their research by posting a free draft copy of their article to any repository or website.
Compliance 'CC BY' license helps in:
| Permission to read and download | ✓ |
| Permission to display in a repository | ✓ |
| Permission to translate | ✓ |
| Commercial uses of manuscript | ✓ |
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
Buccheri V, Barreto WG, Fogliatto LM, Capra M, Marchiani M. Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation. Ann Hematol. 2018; 97: 2269-2278. PubMed: https://pubmed.ncbi.nlm.nih.gov/30315344/
Stankovic T, Skowronska A. The role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia. Leuk Lymphoma. 2014; 55: 1227-1239. PubMed: https://pubmed.ncbi.nlm.nih.gov/23906020/
Stilgenbauer S, Lichter P, Dohner H. Genetic features of B cell chronic Lympocytic leukemia. Rev Clin Exp Hematol. 2000; 4: 48-72. PubMed: https://pubmed.ncbi.nlm.nih.gov/11486330/
Oliveira-Junior RJ, Filho LRG, Bastos LM, Alves DD, Vaz dos Santis S. Contribution of cytogenetics to cancer research. 2014; 30: 245-259.
Barra V, Fachinetti D. The dark side of centromeres: types, causes and consequences of structural abnormalities implicating centromeric DNA. Nat Commun. 2018; 9: 4340. PubMed: https://pubmed.ncbi.nlm.nih.gov/30337534/
Khanna KK, Stephen PJ. DNA double-strand breaks: signaling, repair and the cancer connection. Nat Genet. 2001; 27: 247-254. PubMed: https://pubmed.ncbi.nlm.nih.gov/11242102/
Schaffner C, Idler I, Stilgenbauer S, Dohner H. Lichter P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci USA. 2000; 97: 2773-2778. PubMed: https://pubmed.ncbi.nlm.nih.gov/10706620/
Shaffer LG, McGowan-Jordan J, Schmid M. An International System for Human Cytogenetic Nomenclature (ISCN). Basel. 2013.